|
|
|
Medical Advisory Board Robert Cantu, MD, Medical Advisory Board Chair (bio)
Chief of Neurosurgery Service, Director of Sports Medicine, Emerson Hospital, Concord, MA Dr. Cantu serves as Chief of Neurosurgery Service, Chairman Department of Surgery, and Director of Sports Medicine at Emerson Hospital in Concord, Massachusetts, adjunct professor Exercise and Sport Science, University North Carolina, Chapel Hill, Co-Director, Neurological Sports Injury Center, Brigham and Women’s Hospital, Boston, Neurosurgical Consultant to the Boston Eagles football team, and Neurosurgical Consultant to the Boston Cannons professional lacrosse team. Dr. Cantu is medical director of the National Center for Catastrophic Sports Injury Research, an ongoing registry instituted in 1982 for data collection and analysis of spine and head injuries. He also serves on the Board of Trustees as Vice President of NOCSAE (National Operating Committee on Standards for Athletic Equipment). He served as President of the American College of Sports Medicine (ACSM), the oldest and largest sports medicine and exercise science organization in the world, from 1992 to 1993 and as treasurer from 1996 to 1999. He received their Citation Award in 1996. At the 2007 ACSM’s annual meeting, Dr. Cantu was asked to give the prestigious J.B. Dill Lecture, and presented "The History of Concussions." He has authored over 300 scientific publications, including 21 books on neurosurgery and sports medicine, in addition to numerous book chapters, peer-reviewed papers, abstracts and free communications, and educational videos. Dr. Cantu published the first ever return-to-play guidelines for sports concussions in 1986. Slightly revised in 2001 and still the most widely recognized guidelines by athletic trainers, he devised the first grading system for concussions based on symptoms at the time of injury (Grades 1, 2, 3) and provided medical professionals with concussion management guidelines where there existed none before. Dr Cantu received his B.A. degree from the University of California Berkley and his M.A. degree in endocrinology and M.D. from the University of California Medical School in San Francisco. James C. Beck, MD, PhD (bio)
Associate Director, Law & Psychiatry Service, Massachusetts General Hospital Professor of Psychiatry, Harvard Medical School James C. Beck, MD, PhD is Professor of Psychiatry at Harvard Medical School and Associate Director of the Law & Psychiatry Program at Massachusetts General Hospital. He has been a member of a general hospital department of psychiatry for almost 35 years. His interest in the Sports Legacy Institute grows out of his clinical work and also from his strong commitment to public health. The Sports Legacy Institute is important both for what it can do to raise public awareness of sports related head trauma, and to offer consultation to individuals who may be suffering as a result of these injuries. Ann McKee, MD (bio)
Associate Professor of Neurology & Pathology, Boston University School of Medicine Director, Neuropathology Core, Alzheimer's Disease Center, Boston University Dr. McKee is the chief neuropathologist for the Framingham Heart Study (FHS), where ongoing surveillance of the FHS participants will determine the incidence and type of dementia in persons in the 9th through the 11th decades of life, the oldest old. Dr. McKee directs the Neuropathology Core of the Center, where she is responsible for conducting neuropathological analyses of brain tissue and maintaining the Center’s Brain Bank. Dr. McKee also leads clinical-pathological case conferences as part of the Center’s Research Seminar series. Dr. McKee is a past recipient of the Moore Award and a recent recipient of the 2006 Moore Award Honorable Mention from the American Association of Neuropathologists. She is also a recipient of a Merit Award from the Department of Veterans Affairs. Dr. McKee completed her undergraduate studies at the University of Wisconsin and received her medical degree from the Case Western Reserve School of Medicine. She completed residency training in neurology at Cleveland Metropolitan General Hospital and fellowship training in neuropathology at Massachusetts General Hospital. She was Assistant Professor of Neuropathology at Harvard Medical School from 1991-94, when she became Associate Professor of Neurology and Pathology at Boston University School of Medicine. Dr. McKee has served as Director of the Neuropathology Core of the BU ADCC since its inception in 1996. Robert Stern, PhD (bio)
Associate Professor of Neurology, Co-Director Alzheimer's Disease Clinical and Research Program, Associate Clinical Core Director, Alzheimer's Disease Center; Boston University School of Medicine Dr. Robert Stern is Associate Professor of Neurology at Boston University School of Medicine, where he is also Co- Director of the Alzheimer’s Disease Clinical and Research Program, and Associate Director of the Clinical Core of the BU Alzheimer’s Disease Center, one of 30 centers funded by the National Institute on Aging. Prior to joining the BU faculty, he was on the faculty at Brown Medical School from 1993-2003, where he was Associate Professor of Psychiatry & Neurology, the Director of Neuropsychology and the Memory and Cognitive Assessment Program at Rhode Island Hospital, and where he played an active role overseeing clinical and research training programs in neuropsychology. At Boston University School of Medicine, he is an active educator and mentor; he is the director of a post-doctoral fellowship training program in neuropsychology; he is the director for the graduate course on neuropsychological assessment; and he supervises several masters and doctoral dissertations. Dr. Stern has published on various aspects of neuropsychological assessment and is the senior author of several neuropsychological tests and instruments, including the Neuropsychological Assessment Battery (NAB), a comprehensive battery of 33 new tests, the development of which was funded, in part, by the National Institutes of Health. His primary areas of funded research include cognitive and emotional aspects of dementia, thyroid-brain relationships, and driving and dementia. He also oversees several clinical trials of new treatments for Alzheimer’s disease. Dr. Stern has received several NIH and other national and local grants, has published over 200 journal articles, chapters, and abstracts, and is a Fellow of both the American Neuropsychiatric Association and the National Academy of Neuropsychology. He is a member of the Medical and Scientific Advisory Committee of the Massachusetts Chapter of the Alzheimer’s Association, and is a member of the Medical Advisory Board of the National Graves’ Disease Foundation. Dr. Stern has served on several national grant review committees, and is on the Editorial Boards of the Journal of Neuropsychiatry and Clinical Neurosciences and Archives of Clinical Neuropsychology. |
|||||||||||||||||||||||||||||||||||||||||||||
| |
